$ Value
$267K
Shares
1,250
Price
$213
Filed
Nov 21
Insider
Name
Baynes Roy D.
Title
—
CIK
0001680739
Roles
Transaction Details
Transaction Date
2025-11-19
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,221
Footnotes
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.18 to $214.1550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.35 to $215.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.55 to $216.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.42 to $222.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.46 to $223.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.49 to $224.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.72 to $224.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option shares are fully exercisable.
Filing Info
Baynes Roy D.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-14 | TVTX | M | $144K |
| 2026-04-14 | TVTX | M | $139K |
| 2026-04-14 | TVTX | M | $82K |
| 2026-04-14 | TVTX | M | $96K |
| 2026-04-14 | TVTX | M | $115K |
| 2026-04-14 | TVTX | ▼ | $1.1M |
| 2026-04-14 | TVTX | ▼ | $284K |
| 2026-04-14 | TVTX | M | $0 |
| 2026-04-14 | TVTX | M | $0 |
| 2026-04-14 | TVTX | M | $0 |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |